Article
Palbociclib and Rapamycin pretreatment boosted the persistence and functionality of CAR-T cells in solid tumors through metabolic reprogramming
2026-02-16
Abstract excerpt
<title>Abstract</title> <p> <bold>Background:</bold> Chimeric antigen receptor T cell (CAR-T) therapy has shown remarkable success in treating hematologic malignancies; however, its efficacy against solid tumors remains limited due to the immunosuppressive tumor microenvironment. Enhancing CAR-T cell persistence and function through the use of culture media additives offers a potential strategy to overcome thes...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 38b076fc-c18d-567c-bbf3-ea88479f9ef1
- DOI
- 10.21203/rs.3.rs-8788062/v1
